SG Americas Securities’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

SG Americas Securities’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-63,616	Closed	-$1.14M	–	3745
2017 Q4	$1.14M	Buy	63,616 +53,134	+507%	+$654K	0.01%	1283
2017 Q3	$124K	Sell	10,482 -1,495	-12%	-$16.8K	﹤0.01%	3028
2017 Q2	$126K	Buy	11,977 +631	+6%	+$6.43K	﹤0.01%	2756
2017 Q1	$125K	Sell	11,346 -13,520	-54%	-$157K	﹤0.01%	2824
2016 Q4	$337K	Buy	+24,866	New	+$347K	﹤0.01%	1966
2016 Q3	–	Sell	-40,316	Closed	-$442K	–	3581
2016 Q2	$442K	Buy	+40,316	New	+$451K	﹤0.01%	1765
2015 Q1	–	Sell	-8,120	Closed	-$116K	–	3300
2014 Q4	$116K	Buy	+8,120	New	+$85.8K	﹤0.01%	2821

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

SG Americas Securities's SCMP Position: Q1 2018 in Review

SG Americas Securities sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 63,616 shares — an estimated $1.14M sold.

SG Americas Securities first reported a position in SCMP in Q4 2014 and held it in 7 quarters. The position peaked at $1.14M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

SG Americas Securities reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
SG Americas Securities sold 63,616 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.14M.
SG Americas Securities first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 7 quarters.
SG Americas Securities's Sucampo Pharmaceuticals, Inc. position peaked at $1.14M in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on SG Americas Securities's 13F filing for Q1 2018, filed 3 May 2018.